Prosecution Insights
Last updated: April 19, 2026

Sun Pharmaceutical Industries, Ltd.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
2
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18674352 METHODS FOR TREATING PLAQUE PSORIASIS JIANG, DONG 1674 Non-Final OA May 24, 2024
18590539 TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF REYNOLDS, FRED H 1658 Non-Final OA Feb 28, 2024
18278583 DEXAMETHASONE FOR TREATMENT OF BLEPHARITIS KIDWELL, MICHELE M 3781 Non-Final OA Aug 23, 2023
18317625 MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION OF QUETIAPINE MERCIER, MELISSA S 1615 Non-Final OA May 15, 2023
18249055 GLP-1/GIP DUAL AGONISTS KOMATSU, LI N 1658 Final Rejection Apr 13, 2023
18158767 METHODS FOR TREATMENT OF SUBJECTS WITH PLAQUE PSORIASIS OF THE SCALP DONOGHUE, BRITTNEY ERIN 1675 Non-Final OA Jan 24, 2023
18002478 LONG ACTING GLP-1/GIP DUAL AGONISTS NIEBAUER, RONALD T 1658 Non-Final OA Dec 19, 2022
17443766 STABLE AQUEOUS INJECTABLE SOLUTION OF EPINEPHRINE SOROUSH, LAYLA 1622 Final Rejection Jul 27, 2021

Managing Sun Pharmaceutical Industries, Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month